This website is best viewed on a mobile device that's turned side-ways. Desktop and laptop users, use control + to increase zoom for 175% for optimal viewing. Scroll down for your content!
First let's talk about the hero which provided much of the research cited in this article. Believe it or not, this man was also credited with supplying seeds of Mitragyna speciosa outside Thailand, which makes him worthy of our gratitude. His name is Claude Rifat, and you probably recognize the name "rifat" from many vendors who sell strains named after this guy. He's a French biologist, psychonaut, political activist, writer, and researcher. He distinguishes oneirogens into two categories which I will discuss in the next paragraph. Oneirogen, by the way, means "dream generating".
Claude's considers pre-oneirogens as substances that increase the production of hypnagogic imagery as well as hypnopompic imagery. These are two states of consciousness that have to do with entering sleep, and awakening from sleep. The fact that this brilliant researcher was able to break down this classification into even more detailed sub-categories can really help a psychonaut who's learning about various types of dream inducing plants. The idea is to utilize specific types of oneirogens at the right time, and in the right fashion.
The most interesting part of his work I think is the fact that he discovered that both Cannabis and Psilocybin are actually pre-oneirogens! A lot of oneironauts ( dream explorers ) claim that Marijuana makes lucid dreaming and dream recall more difficult, and this may be true. The point of his research I believe is that these substances tend to stimulate our awareness and expand our consciousness in the waking state. Thus, when used properly one should be able to use them to enhance their lucidity and practices that revolve around the art. Our survival depends on awareness, as what we don't know often times can hurt or destroy us.
Another interesting point that i'd like to add, which many people are unaware of, is that the active ingredients in psilocybin mushrooms are literally forms of DMT.[3] DMT is the active chemical in our brains associated with sleep, dreams, and other mystical experiences. Psilocin is actually 4-HO-DMT, while psilocybin is literally 4-PO-DMT. Because of this, is it any surprise that these substances are oneirogenic in nature? It also makes you wonder why they are illegal. I wanted to take one last minute to give a shout out to MAPS. Please feel free to check them out and support their work. MAPS stands for Multidisciplinary Association for Psychedelic Studies and they are very important people for this world. There are other important American organizations listed under the references and resources section.
INFORMATION PROVIDED ON OUR WEBSITE IS FOR BOTANICAL/CULTURAL RESEARCH PURPOSES ONLY! ANY REFERENCES ABOUT THE USE OR EFFECTS OF THESE NATURAL HEALING HERBS IS BASED ON TRADITIONAL USE OR SHAMANIC PRACTICES. ALL PRODUCTS ARE SOLD FOR ETHNOBOTANICAL RESEARCH (CONSULT YOUR HEALTHCARE PROVIDER)! NOT EVALUATED OR APPROVED BY THE FDA. NOT INTENDED TO DIAGNOSE, TREAT, PREVENT, OR CURE, ANY AILMENTS, CONDITIONS, DISEASES, ETC.
Toro, G., & Thomas, B. (2007). Drugs of the dreaming: oneirogens: Salvia divinorum and other dream-enhancing plants. Rochester, VT: Park Street Press.
Glennon R.A.; Titeler M.; McKenney J.D. (December 1984). "Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents". Life Sciences. 35 (25): 2505–11. doi:10.1016/0024-3205(84)90436-3. PMID 6513725
Carbonaro, Theresa M.; Gatch, Michael B. (September 2016). "Neuropharmacology of N,N-dimethyltryptamine". Brain Research Bulletin. 126 (Pt. 1): 74–88. doi:10.1016/j.brainresbull.2016.04.016. PMC 5048497. PMID 27126737
McKenna, Dennis J.; Towers, G. H. N.; Abbott, F. (April 1984). "Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of ayahuasca". Journal of Ethnopharmacology. 10 (2): 195–223. doi:10.1016/0378-8741(84)90003-5. ISSN 0378-8741. PMID 6587171.
Corothie, E; Nakano, T (1969). "Constituents of the bark of Virola sebifera". Planta Medica. 17 (2): 184–188. doi:10.1055/s-0028-1099844. PMID 5792479.
Rivier, Laurent; Lindgren, Jan-Erik (1972). "'Ayahuasca,' the South American hallucinogenic drink: An ethnobotanical and chemical investigation". Economic Botany. 26 (2): 101–129. doi:10.1007/BF02860772. ISSN 0013-0001.
Strassman R.J.; Qualls C.R. (February 1994). "Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects". Archives of General Psychiatry. 51 (2): 85–97. doi:10.1001/archpsyc.1994.03950020009001. PMID 8297216.
Claude Rifat. (2016, March 10). In Wikipedia, The Free Encyclopedia. Retrieved 19:51, February 8, 2017, from https://en.wikipedia.org/w/index.php?title=Claude_Rifat&oldid=709367693
